Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Serum miRNAs predicting sustained HBs antigen reduction 48 weeks after pegylated interferon therapy in HBe antigen-negative patients
Koji Fujita
, Shima Mimura
, Hisakazu Iwama
, Mai Nakahara
, Kyoko Oura
, Tomoko Tadokoro
, Takako Nomura
, Joji Tani
, Hirohito Yoneyama
, Asahiro Morishita
, Makoto Oryu
, Takashi Himoto
,
Hironori Nishitsuji
, Kunitada Shimotohno
, Masao Omata
, Tsutomu Masaki
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serum miRNAs predicting sustained HBs antigen reduction 48 weeks after pegylated interferon therapy in HBe antigen-negative patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
interferon
100%
Interferon
100%
Hepatitis B Virus
100%
MicroRNA
80%
DNA Virus
40%
Transaminase
20%
Virus Replication
20%
Supernatant
20%
Alanine
20%
Liver Function
20%
Antiviral Activity
20%
Immunology and Microbiology
Pegylated Interferon
100%
Hepatitis B Virus
75%
DNA Virus
50%
Hepatitis B
50%
Viral Replication
25%
Supernatant
25%
Liver Function
25%
Antiviral Activity
25%
Keyphrases
HBe Antigen
100%
Seroclearance
11%
Sodium taurocholate Cotransporting Polypeptide
11%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Bile Acid Cotransporter
20%
Antiviral Activity
20%